REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 120 filers reported holding REVOLUTION MEDICINES INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,867,980 | +51.7% | 320,375 | +46.6% | 0.00% | 0.0% |
| Q2 2023 | $5,844,367 | -71.3% | 218,481 | -76.8% | 0.00% | -50.0% |
| Q1 2023 | $20,397,937 | +94.0% | 941,733 | +113.3% | 0.00% | +100.0% |
| Q4 2022 | $10,514,505 | +145.3% | 441,415 | +103.1% | 0.00% | 0.0% |
| Q3 2022 | $4,287,000 | +108.6% | 217,378 | +106.1% | 0.00% | – |
| Q2 2022 | $2,055,000 | -61.7% | 105,458 | -49.9% | 0.00% | -100.0% |
| Q1 2022 | $5,371,000 | +556.6% | 210,575 | +547.8% | 0.00% | – |
| Q4 2021 | $818,000 | +46.1% | 32,506 | +59.7% | 0.00% | – |
| Q3 2021 | $560,000 | -37.9% | 20,357 | -28.4% | 0.00% | – |
| Q2 2021 | $902,000 | +55.0% | 28,433 | +123.9% | 0.00% | – |
| Q1 2021 | $582,000 | +59.0% | 12,701 | +37.2% | 0.00% | – |
| Q4 2020 | $366,000 | +3.4% | 9,259 | -8.9% | 0.00% | – |
| Q3 2020 | $354,000 | +80.6% | 10,167 | +63.7% | 0.00% | – |
| Q2 2020 | $196,000 | -37.4% | 6,209 | -56.5% | 0.00% | – |
| Q1 2020 | $313,000 | – | 14,275 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,524,031 | $151,966,000 | 28.85% |
| Ponoi II Management, LLC | 685,011 | $18,845,000 | 27.92% |
| Ponoi Management, LLC | 685,011 | $18,845,000 | 16.73% |
| Column Group LLC | 3,347,245 | $92,083,000 | 10.48% |
| TRV GP IV, LLC | 1,419,900 | $39,061,000 | 8.86% |
| Cormorant Asset Management, LP | 3,144,700 | $86,511,000 | 3.52% |
| Boxer Capital, LLC | 3,484,264 | $95,852,000 | 3.35% |
| BVF INC/IL | 2,485,049 | $68,364,000 | 2.67% |
| Casdin Capital, LLC | 2,800,000 | $77,028,000 | 1.92% |
| COMMODORE CAPITAL LP | 226,228 | $6,224,000 | 1.64% |